Standard BioTools to Participate in Upcoming Investor Conferences

Group 1 - Standard BioTools Inc. will participate in several investor conferences in June 2024, including the Jefferies Global Healthcare Conference and the TD Cowen's 3rd Annual Tool/Dx Revolution Conference [1][4] - The company is known for its portfolio of next-generation technologies that aid biomedical researchers in developing medicines more efficiently [2] - Standard BioTools focuses on providing insights in health and disease through its proprietary mass cytometry and microfluidics technologies, addressing needs in translational and clinical research, particularly in oncology and immunology [2] Group 2 - The President and CEO, Michael Egholm, PhD, will engage in a fireside chat at the Jefferies Global Healthcare Conference on June 5th and participate in a panel discussion at the TD Cowen's conference on June 25th [4] - The company has a strong presence in various research sectors, including academic, government, pharmaceutical, and biotechnology, emphasizing its role in improving patient outcomes [2]